Adaptive Biotechnologies - Stock Price History | ADPT
Historical daily share price chart and data for Adaptive Biotechnologies since 2021 adjusted for splits. The latest closing stock price for Adaptive Biotechnologies as of September 27, 2021 is 35.83.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
- The all-time high Adaptive Biotechnologies stock closing price was 67.74 on January 22, 2021.
- The Adaptive Biotechnologies 52-week high stock price is 71.25, which is 98.9% above the current share price.
- The Adaptive Biotechnologies 52-week low stock price is 29.73, which is 17% below the current share price.
- The average Adaptive Biotechnologies stock price for the last 52 weeks is 45.26.
|Adaptive Biotechnologies Historical Annual Stock Price Data
||Average Stock Price
||Annual % Change
||Medical - Biomedical and Genetics
Adaptive Biotechnologies Corporation is a commercial-stage biotech company. It develops and commercializes immune-driven clinical products to transform the diagnosis and treatment of disease. The company's product pipeline includes immunoSEQ, clonoSEQ and cellular therapy which are in clinical stage. Adaptive Biotechnologies Corporation is based in Seattle, Washington.